Malad East, Mumbai, Maharashtra
Send E-mail
Send SMS
Home»Products»

Trastuzumab 440 mg

Trastuzumab Medicine usually is administered intravenously with an initial dose of 4 mg per kilogram of body weight followed by a weekly dose of 2 mg per kilogram of body weight. This is effectual in the treatment of an early stage breast cancer commonly found in the women.


REQUEST CALLBACK
Get Best Quote

Approx. Rs 500  / Piece Get Latest Price

Trastuzumab Drug is approved for the treatment of early-stage breast cancer that is Human Epidermal growth factor Receptor 2-positive (HER2+) and has spread into the lymph nodes, or is HER2+ and has not spread into the lymph nodes. If it has not spread into the lymph nodes, the cancer needs to be estrogen receptor/progesterone receptor (ER/PR)-negative or have one high risk feature.

Trastuzumab is approved to be used alone or with other drugs to treat:

 

  • Adenocarcinoma of the stomach or gastroesophageal junction. It is used for HER2 positive (HER2+) disease that has metastasized (spread to other parts of the body) in patients who have not already been treated for metastatic cancer

  • Breast cancer that is HER2+. It is used in patients whose disease has not gotten better with other chemotherapy

  • Trastuzumab usually is administered intravenously with an initial dose of 4 mg per kilogram of body weight followed by a weekly dose of 2 mg per kilogram of body weight

Yes! I am Interested
X
 

Download Brochure
Explore more products
Ixempra 45 Mg
Get Best Quote
Taxotere 80 Mg
Get Best Quote
Rituximab Injection
Get Best Quote
Fibrin Sealant Kits
Get Best Quote
Pegfilgrastim Medication
Get Best Quote
3s Corporation

Piyansh Mantry(CEO)
B/22 Padamnagar CHS, Andheri Kurla Road, Andheri East
Malad East, Mumbai - 400101
Maharashtra, India
Send Email
© 3s Corporation. All Rights Reserved (Terms of Use)
Developed and Managed by IndiaMART InterMESH Limited